Updating results

1901 results

Sort: Relevance | Date

Icare rebound tonometer to measure intraocular pressure (MIB57)

Advice on the use of the Icare rebound tonometer to measure intraocular pressure and assess the risk of developing glaucoma to aid local decision-making

Medtech innovation briefing Published March 2016

Prolaris gene expression assay for assessing long-term risk of prostate cancer progression (MIB65)

Advice on the use of the Prolaris gene expression assay for assessing the risk of prostate cancer progression to aid local decision-making

Medtech innovation briefing Published May 2016

ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot (MIB56)

Advice on the use of ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot to aid local decision-making

Medtech innovation briefing Published March 2016

AccuVein AV400 for vein visualisation (MIB6)

Advice on the use of AccuVein AV400 for vein visualisation (peripheral venous access) to aid local decision-making

Medtech innovation briefing Published June 2014

TheraSphere for treating operable and inoperable hepatocellular carcinoma (MIB62)

Advice on the use of TheraSphere for treating operable and inoperable hepatocellular carcinoma (liver cancer) to aid local decision-making

Medtech innovation briefing Published March 2016

CareLink network service for remote monitoring of people with cardiac devices (MIB64)

Advice on the use of the CareLink network service for monitoring cardiac devices to aid local decision-making

Medtech innovation briefing Published May 2016

Mobi-C for cervical disc replacement (MIB70)

Advice on the use of Mobi-C for cervical disc replacement to aid local decision-making

Medtech innovation briefing Published June 2016

Peptest for diagnosing gastro‑oesophageal reflux (MIB31)

Advice on the use of the Peptest for diagnosing gastro-oesophageal reflux disease (GORD) to aid local decision-making

Medtech innovation briefing Published May 2015

Spiral Flow peripheral vascular graft for treating peripheral arterial disease (MIB34)

Advice on the use of the Spiral Flow peripheral vascular (PV) graft for treating peripheral arterial disease (PAD) to aid local decision-making

Medtech innovation briefing Published July 2015

BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis (MIB32)

Advice on the use of the BD MAX Enteric Bacterial Panel (EBP) for identifying pathogens in contagious gastroenteritis to aid local decision-making

Medtech innovation briefing Published July 2015

LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)

Advice on the use of the LARS (ligament augmentation and reconstruction system) for reconstructing damaged intra-articular cruciate knee ligaments...

Medtech innovation briefing Published May 2015

ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment (MIB39)

Advice on the use of ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment to aid local decision-making

Medtech innovation briefing Published September 2015

i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

Advice on the use of the i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department to aid local decision-making

Medtech innovation briefing Published September 2015

PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)

Advice on the use of the PROPATEN heparin-bonded vascular graft for treating peripheral arterial disease to aid local decision-making

Medtech innovation briefing Published October 2015

Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)

Advice on the Xpert Carba-R test for identifying organisms that have carbapenemase genes to aid local decision-making

Medtech innovation briefing Published February 2016

Antimicrobial stewardship: prescribing antibiotics (KTT9)

KTT9 Antimicrobial stewardship: prescribing antibiotics Key points Antimicrobial resistance

Key therapeutic topic Published January 2015 Last updated September 2019

The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns (MIB1)

Advice on the use of the Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns to aid local decision-making

Medtech innovation briefing Published February 2014

NaviCam for diagnosing gastrointestinal tract conditions (MIB104)

Advice on the use of NaviCam for diagnosing gastrointestinal (GI) tract and small bowel conditions to aid local decision-making

Medtech innovation briefing Published May 2017

The SENSIMED Triggerfish contact lens sensor for continuous 24-hour recording of ocular dimensional changes in people with or at risk of developing glaucoma (MIB14)

Advice on the use of the SENSIMED Triggerfish contact lens sensor for use in people with or at risk of developing glaucoma

Medtech innovation briefing Published November 2014

The Airsonett temperature-controlled laminar airflow device for persistent allergic asthma (MIB8)

Advice on the use of the Airsonett temperature-controlled laminar airflow device for persistent allergic asthma to aid local decision-making

Medtech innovation briefing Published August 2014

Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)

Advice on the use of Woundchek Protease Status for assessing elevated protease status in chronic wounds to aid local decision-making

Medtech innovation briefing Published October 2016

Non-cystic fibrosis bronchiectasis: inhaled tobramycin (ES12)

ES12 Non-cystic fibrosis bronchiectasis: inhaled tobramycin Key points

Evidence summary Published April 2017

The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)

Advice on the use of the hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability to aid local decision-making

Medtech innovation briefing Published August 2014

Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)

Advice on the use of the Alair bronchial thermoplasty system for treating adults with severe, difficult to control asthma to aid local decision-making

Medtech innovation briefing Published July 2016

Stretta System for gastro-oesophageal reflux disease (MIB74)

Advice on the use of Stretta System for gastro-oesophageal reflux disease (GORD)

Medtech innovation briefing Published July 2016

OSNA for colon cancer staging (MIB77)

Advice on the use of OSNA in vitro diagnostic molecular assay system for staging colon cancer to aid local decision-making

Medtech innovation briefing Published August 2016

The NGAL Test for early diagnosis of acute kidney injury (MIB3)

Advice on the use of the NGAL Test for early diagnosis of acute kidney injury (AKI) to aid local decision-making

Medtech innovation briefing Published February 2014

Episcissors-60 for guided mediolateral episiotomy (MIB33)

Advice on the use of the Episcissors-60 for guided mediolateral episiotomy to aid local decision-making

Medtech innovation briefing Published July 2015

Visensia for early detection of deteriorating vital signs in adults in hospital (MIB36)

Advice on the use of the Visensia for early detection of deteriorating vital signs in adults in hospital to aid local decision-making

Medtech innovation briefing Published August 2015

The OSCAR 3 ultrasonic arthroplasty revision instrument for removing bone cement during prosthetic joint revision (MIB13)

Advice on the use of the OSCAR 3 ultrasonic arthroplasty revision instrument for removing bone cement during prosthetic joint revision..

Medtech innovation briefing Published November 2014

The PressureWire fractional flow reserve measurement system for coronary artery disease (MIB2)

Advice on the use of the PressureWire fractional flow reserve measurement system for coronary artery disease to aid local decision-making

Medtech innovation briefing Published February 2014

Generalised anxiety disorder: quetiapine (ESUOM12)

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Non-cystic fibrosis bronchiectasis: colistimethate sodium (ESUOM25)

Summary of the evidence on colistimethate sodium (Colobreathe) for non-cystic fibrosis bronchiectasis to inform local NHS planning and decision-making

Evidence summary Published January 2014

Schizophrenia: omega-3 fatty acid medicines (ESUOM19)

Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making

Evidence summary Published September 2013

Postural hypotension in adults: fludrocortisone (ESUOM20)

Summary of the evidence on fludrocortisone for treating postural hypotension in adults to inform local NHS planning and decision-making

Evidence summary Published October 2013

Chronic obstructive pulmonary disease: glycopyrronium bromide (ESNM9)

Summary of the evidence on glycopyrronium bromide for treating chronic obstructive pulmonary disease (COPD) to inform local NHS planning and decision-making

Evidence summary Published January 2013

Gastroparesis in adults: oral erythromycin (ESUOM13)

Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making

Evidence summary Published June 2013

Hyperhidrosis: oral glycopyrronium bromide (ESUOM16)

Summary of the evidence on oral glycopyrronium bromide for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

Evidence summary Published July 2013

Bile acid malabsorption: colesevelam (ESUOM22)

Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

Evidence summary Published October 2013

Difficult-to-treat scabies: oral ivermectin (ESUOM29)

Summary of the evidence on oral ivermectin for treating difficult-to-treat scabies to inform local NHS planning and decision-making

Evidence summary Published March 2014

Interstitial cystitis: dimethyl sulfoxide bladder instillation (ESUOM26)

Summary of the evidence on dimethyl sulfoxide bladder instillation for treating interstitial cystitis to inform local NHS planning and decision-making

Evidence summary Published February 2014

Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream (ESNM68)

Summary of the evidence on ivermectin 10 mg/g cream for treating papulopustular rosacea to inform local NHS planning and decision-making

Evidence summary Published January 2016

Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)

Summary of the evidence on high-strength insulin glargine 300 units/ml (Toujeo) for type 1 diabetes mellitus to inform local NHS planning and decision-making

Evidence summary Published October 2015

Facial erythema of rosacea: brimonidine tartrate gel (ESNM43)

Summary of the evidence on brimonidine tartrate gel for treating facial erythema of rosacea to inform local NHS planning and decision-making

Evidence summary Published July 2014

Systemic juvenile idiopathic arthritis: canakinumab (ESNM36)

Summary of the evidence on canakinumab for treating systemic juvenile idiopathic arthritis (JIA) to inform local NHS planning and decision-making

Evidence summary Published March 2014

Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)

Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making

Evidence summary Published July 2015

Type 2 diabetes: alogliptin (ESNM20)

Summary of the evidence on alogliptin (a dipeptidyl peptidase-4 [DPP-4] inhibitor) for type 2 diabetes to inform local NHS planning and decision-making

Evidence summary Published May 2013 Last updated October 2014

Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate (ESNM19)

Summary of the evidence on lisdexamfetamine dimesylate for attention defecit hyperactivity disorder (ADHD) in children and young people..

Evidence summary Published May 2013

Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil (ESNM18)

Summary of the evidence on tadalafil for lower urinary tract symptoms secondary to benign prostate hyperplasia..

Evidence summary Published May 2013 Last updated October 2013

Actinic keratosis: ingenol mebutate gel (ESNM14)

Summary of the evidence on ingenol mebutate gel for actinic keratosis (solar keratosis) to inform local NHS planning and decision-making

Evidence summary Published March 2013